Difference between revisions of "Hypercoagulable state (thrombophilia)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer. If this is your first time visiting, we suggest you read the tutorial.'''" to "<!--'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer. If this is your first time visiting, we suggest you read the tutorial.'''-->") |
m (→Guidelines) |
||
| (7 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
| − | |||
| − | |||
==Inherited thrombophilias== | ==Inherited thrombophilias== | ||
*Prothrombin gene mutation (G20210A) | *Prothrombin gene mutation (G20210A) | ||
| Line 14: | Line 12: | ||
==Acquired thrombophilias and clotting risk factors== | ==Acquired thrombophilias and clotting risk factors== | ||
| − | *Surgery, foreign bodies such as venous catheters, smoking, obesity, elevated factor VIII, advanced age, male sex, trauma, sedentary state, immobilization, malignancy, myeloproliferative disorders--[[polycythemia vera | polycythemia vera (PV)]], [[Essential thrombocythemia | essential thrombocythemia (ET)]], [[Myelofibrosis | primary myelofibrosis (PMF)]], pregnancy, medications--e.g. [[Bevacizumab (Avastin)]], [[Lenalidomide (Revlimid)]], [[Thalidomide (Thalomid)]], [[Tamoxifen (Nolvadex)]], oral contraceptive use, [[heparin]]--in the case of heparin-induced thrombocytopenia/thrombosis (HIT), congestive heart failure, anatomic/low cardiovascular flow states--e.g. inferior vena cava (IVC) abnormalities, chronic inflammation, inflammatory bowel disease, nephrotic syndrome, [[ | + | *[[Surgery]], foreign bodies such as venous catheters, smoking, obesity, elevated factor VIII, advanced age, male sex, trauma, sedentary state, immobilization, malignancy, myeloproliferative disorders--[[polycythemia vera | polycythemia vera (PV)]], [[Essential thrombocythemia | essential thrombocythemia (ET)]], [[Myelofibrosis | primary myelofibrosis (PMF)]], pregnancy, medications--e.g. [[Bevacizumab (Avastin)]], [[Lenalidomide (Revlimid)]], [[Thalidomide (Thalomid)]], [[Tamoxifen (Nolvadex)]], oral contraceptive use, [[heparin]]--in the case of heparin-induced thrombocytopenia/thrombosis (HIT), congestive heart failure, anatomic/low cardiovascular flow states--e.g. inferior vena cava (IVC) abnormalities, chronic inflammation, inflammatory bowel disease, nephrotic syndrome, [[Paroxysmal_nocturnal_hemoglobinuria | paroxysmal noctural hemoglobinuria (PNH)]] |
*Prior venous thromboembolism (VTE) | *Prior venous thromboembolism (VTE) | ||
*Antiphospholipid antibody syndrome (APS) | *Antiphospholipid antibody syndrome (APS) | ||
| Line 21: | Line 19: | ||
**Beta 2 glycoprotein 1 (B2GP1) IgG, IgM, IgA | **Beta 2 glycoprotein 1 (B2GP1) IgG, IgM, IgA | ||
**Sapporo criteria for APS | **Sapporo criteria for APS | ||
| + | |||
| + | ==Related pages== | ||
| + | *[[Antiphospholipid antibody syndrome]] | ||
| + | *[[Inherited thrombophilia]] | ||
| + | *[[Venous thromboembolism]] | ||
==References== | ==References== | ||
| + | *[https://pubmed.ncbi.nlm.nih.gov/25724822 Moll S. Thrombophilia: clinical-practical aspects. J Thromb Thrombolysis. 2015 Apr;39(3):367-78.] | ||
| + | **[https://mobile.twitter.com/THilalMD/status/1183941575300263936 Table of reliability of thrombophilia testing with anticoagulants and in acute thrombosis] | ||
[[Category:Hematology reference pages]] | [[Category:Hematology reference pages]] | ||
Latest revision as of 17:51, 7 September 2023
Inherited thrombophilias
- Prothrombin gene mutation (G20210A)
- Factor V Leiden mutation
- Antithrombin III deficiency
- Protein C deficiency
- Protein S deficiency
- Dysfibrinogenemia
Controversial:
- Plasminogen deficiency
- Factor XII deficiency
Acquired thrombophilias and clotting risk factors
- Surgery, foreign bodies such as venous catheters, smoking, obesity, elevated factor VIII, advanced age, male sex, trauma, sedentary state, immobilization, malignancy, myeloproliferative disorders-- polycythemia vera (PV), essential thrombocythemia (ET), primary myelofibrosis (PMF), pregnancy, medications--e.g. Bevacizumab (Avastin), Lenalidomide (Revlimid), Thalidomide (Thalomid), Tamoxifen (Nolvadex), oral contraceptive use, heparin--in the case of heparin-induced thrombocytopenia/thrombosis (HIT), congestive heart failure, anatomic/low cardiovascular flow states--e.g. inferior vena cava (IVC) abnormalities, chronic inflammation, inflammatory bowel disease, nephrotic syndrome, paroxysmal noctural hemoglobinuria (PNH)
- Prior venous thromboembolism (VTE)
- Antiphospholipid antibody syndrome (APS)
- Lupus anticoagulant: dilute Russell viper venom time (dRVVT), dilute activated partial thromboplastin time (dAPTT), Staclot LA (hexagonal phase phospholipids), Kaolin clotting time (KCT)
- Anticardiolipin (aCL) antibody IgG, IgM, IgA
- Beta 2 glycoprotein 1 (B2GP1) IgG, IgM, IgA
- Sapporo criteria for APS